|
|
|
|
|
by purple_turtle
203 days ago
|
|
The problem in USA is that producing insuline is so regulated that setting up and maintaining production is obnoxiously expensive. Note that if you cause by regulation or stupid laws something to be expensive to produce/import and then make it illegal to sell above that price - then you will get shortages. As noone will want to produce insuline if required paperwork costs more than it's selling price. Note that even if currently adding more regulation to solve problems caused by more regulation will not cause it, it may happen in future. US healthcare regulations are on Nth round of that. |
|
This is what I meant by compete on cost. The manufacturers that are best at cutting these costs will make the most profit. That’s where competition should be focused on such generic items.